A meta-analysis in Rheumatology and Orthopedic Medicine compared the Intertan nail, which uses Smith & Nephew’s proprietary Integrated Compression Screw, with other intertrochanteric nails using a single screw. The analysis featured twelve studies with 1,661 patients. Study authors found Intertan reduced the risk of implant-related failures by 81 percent and revision surgery by 65 percent when compared to single screw nails.
Compared to single screw nails, the Intertan nail led $2,700 in average cost savings per patient, according to a study in Journal of Orthopaedic Surgery and Research. Study authors developed a decision analytic model that assessed 1,000 patients. Cost data was obtained from the CMS website and literature and adjusted for inflation.
“These new studies demonstrate that the integrated compression screw used in the Intertan nail not only improved the clinical outcomes for these patients studied, but also reduced the cost to the overall health economic system by reducing the revision rates, compared to those that have been demonstrated in prior studies,” said orthopedic traumatologist J. Tracy Watson MD, who co-authored both studies.
More articles on devices:
Orthopaedic Implant Company introduces intramedullary nail system
MRI Interventions partners with Clinical Laserthermia Systems to develop spine & navigation platform: 3 notes
Additive Orthopaedics receives funding through New Jersey EDA: 4 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.